By the Director

In 2019, a research team led by the physician and economist Ziad Obermeyer reverse-engineered a commercial algorithm already running quietly across the United States health system. The tool, sold by Optum, helped decide which patients — out of a population of roughly 200 million a year — would be flagged for extra medical attention. To […]